David H. Raulet
Affiliations: | 1991 | Biology | Massachusetts Institute of Technology, Cambridge, MA, United States |
| 1991- | University of California, Berkeley, Berkeley, CA, United States |
Google:
"David Raulet"Cross-listing: Cell Biology Tree
Children
Sign in to add trainee| Dawn Mia Tanamachi | grad student | 2000 | UC Berkeley |
| Russell E. Vance | grad student | 2000 | UC Berkeley |
| Amanda Mercedes Jamieson | grad student | 2003 | UC Berkeley |
| John Joseph Engelhardt | grad student | 2005 | UC Berkeley |
| Tiffany Marie Juarez | grad student | 2007 | UC Berkeley |
| Daniel Marcos Serna | grad student | 2007 | UC Berkeley |
| Ming Yu Hsiung | grad student | 2008 | UC Berkeley |
| Michael Insuk Whang | grad student | 2008 | UC Berkeley |
| Timothy James Nice | grad student | 2004-2009 | UC Berkeley |
| Heiyoun Jung | grad student | 2011 | UC Berkeley |
| Nataliya Shifrin | grad student | 2013 | UC Berkeley |
| James Carlyle | post-doc | 1999-2003 | UC Berkeley (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ren J, Jo Y, Picton LK, et al. (2022) Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. Acs Synthetic Biology |
| Wolf NK, Kissiov DU, Raulet DH. (2022) Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nature Reviews. Immunology |
| Kissiov DU, Ethell A, Chen S, et al. (2022) Binary outcomes of enhancer activity underlie stable random monoallelic expression. Elife. 11 |
| Wolf NK, Blaj C, Picton LK, et al. (2022) Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I tumors. Proceedings of the National Academy of Sciences of the United States of America. 119: e2200568119 |
| Nicolai CJ, Raulet DH. (2020) Killer cells add fire to fuel immunotherapy. Science (New York, N.Y.). 368: 943-944 |
| Nicolai CJ, Wolf N, Chang IC, et al. (2020) NK cells mediate clearance of CD8 T cell-resistant tumors in response to STING agonists. Science Immunology. 5 |
| Luteijn RD, Zaver SA, Gowen BG, et al. (2019) SLC19A1 transports immunoreactive cyclic dinucleotides. Nature. 573: 434-438 |
| Muñoz DP, Yannone SM, Daemen A, et al. (2019) Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging. Jci Insight. 5 |
| Zhang J, Chen HM, Ma G, et al. (2019) The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells. Leukemia |
| Marcus A, Mao AJ, Lensink-Vasan M, et al. (2018) Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 49: 754-763.e4 |